BirchBioMed Inc. has submitted a revised S-1/A filing to the US Securities and Exchange Commission (SEC) on November 19, 2026, according to SEC EDGAR S-1 IPO Filings. The filing, with accession number 0001493152-26-053312, has a total size of 9 MB. This development marks a significant step in BirchBioMed Inc.'s journey towards a potential initial public offering (IPO).